FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

57583000: Naphazoline hydrochloride (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
95748011 Naphazoline hydrochloride en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
796221013 Naphazoline hydrochloride (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
827151000172119 chlorhydrate de naphazoline fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Naphazoline hydrochloride Is a Product containing naphazoline (medicinal product) false Inferred relationship Some
Naphazoline hydrochloride Is a Naphazoline (substance) false Inferred relationship Some
Naphazoline hydrochloride This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Alpha adrenergic receptor agonist (disposition) true Inferred relationship Some
Naphazoline hydrochloride Is a vasoconstricteur false Inferred relationship Some
Naphazoline hydrochloride This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. Naphazoline (substance) true Inferred relationship Some
Naphazoline hydrochloride Is a Imidazole true Inferred relationship Some
Naphazoline hydrochloride Is a Alpha adrenergic receptor agonist true Inferred relationship Some
Naphazoline hydrochloride Is a Adrenergic receptor agonist false Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Naphazoline hydrochloride 120 microgram/mL eye drops Is a False Naphazoline hydrochloride Inferred relationship Some
Naphazoline hydrochloride 120 microgram/mL eye drops The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Naphazoline hydrochloride Inferred relationship Some
Naphazoline hydrochloride 1 mg/mL eye solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Naphazoline hydrochloride Inferred relationship Some
Naphazoline hydrochloride 1mg/mL solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Naphazoline hydrochloride Inferred relationship Some
Naphazoline hydrochloride 0.1%wv solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Naphazoline hydrochloride Inferred relationship Some
Naphazoline hydrochloride 0.012% eye solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Naphazoline hydrochloride Inferred relationship Some
Product containing precisely naphazoline hydrochloride 200 microgram/1 milliliter conventional release eye solution (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Naphazoline hydrochloride Inferred relationship Some
Product containing precisely naphazoline hydrochloride 300 microgram/1 milliliter conventional release eye solution (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Naphazoline hydrochloride Inferred relationship Some
Antazoline phosphate + naphazoline hydrochloride 5mg/0.5mg solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Naphazoline hydrochloride Inferred relationship Some
Naphazoline hydrochloride + polyvinyl alcohol + zinc sulfate 0.02%wv/0.25%wv/0.25%wv drops The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Naphazoline hydrochloride Inferred relationship Some
Antazoline phosphate + naphazoline hydrochloride The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Naphazoline hydrochloride Inferred relationship Some
Naphazoline hydrochloride+pheniramine The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Naphazoline hydrochloride Inferred relationship Some
Naphazoline hydrochloride 250 microgram/mL and pheniramine maleate 3 mg/mL eye solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Naphazoline hydrochloride Inferred relationship Some
Naphazoline hydrochloride 120 microgram/mL eye drops This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Naphazoline hydrochloride Inferred relationship Some 1
Naphazoline hydrochloride 120 microgram/mL eye drops The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Naphazoline hydrochloride Inferred relationship Some 1
Naphazoline hydrochloride 1 mg/mL eye solution This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Naphazoline hydrochloride Inferred relationship Some 1
Naphazoline hydrochloride 1 mg/mL eye solution The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Naphazoline hydrochloride Inferred relationship Some 1
Product containing precisely naphazoline hydrochloride 200 microgram/1 milliliter conventional release eye solution (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Naphazoline hydrochloride Inferred relationship Some 1
Product containing precisely naphazoline hydrochloride 200 microgram/1 milliliter conventional release eye solution (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Naphazoline hydrochloride Inferred relationship Some 1
Product containing precisely naphazoline hydrochloride 300 microgram/1 milliliter conventional release eye solution (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Naphazoline hydrochloride Inferred relationship Some 1
Product containing precisely naphazoline hydrochloride 300 microgram/1 milliliter conventional release eye solution (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Naphazoline hydrochloride Inferred relationship Some 1
Naphazoline hydrochloride 250 microgram/mL and pheniramine maleate 3 mg/mL eye solution This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Naphazoline hydrochloride Inferred relationship Some 2
Naphazoline hydrochloride 250 microgram/mL and pheniramine maleate 3 mg/mL eye solution The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Naphazoline hydrochloride Inferred relationship Some 2
Naphazoline hydrochloride 270 microgram/mL and pheniramine maleate 3.15 mg/mL eye solution This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Naphazoline hydrochloride Inferred relationship Some 2
Naphazoline hydrochloride 270 microgram/mL and pheniramine maleate 3.15 mg/mL eye solution The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Naphazoline hydrochloride Inferred relationship Some 2

This concept is not in any reference sets

Back to Start